Future antiepileptic drug development

Neurology

Volumn 55, Issue 5 SUPPL. 1, 2000, Pages

  Bergey, G K ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Antiepileptic drugs; Drug development; Mechanisms of action

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; ANTICONVULSIVE AGENT; GLUTAMATE TRANSPORTER; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; SEROTONIN;

ANTICONVULSANT ACTIVITY; ARTICLE; DRUG INDICATION; DRUG MECHANISM; DRUG RESEARCH; EPILEPSY; HUMAN; PRIORITY JOURNAL;

ANTICONVULSANTS; EPILEPSY; FORECASTING; HUMANS;

EID: 0033812750     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
2. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
3. Kindling: Clinical relevance for epileptogenicity in humans
4. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
5. Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: Influence of experimental and environmental factors
6. Utility of the lethargic (1h/1h) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures
7. Antiepileptic drug mechanisms of action
8. Glutamate receptors in epilepsy
9. Excitatory amino acid receptors and antiepileptic drug development
10. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors
11. Felbamate block of the N-methyl-D-aspartate receptor
12. Mechanisms of new antiepileptic drugs
13. The glycine site on the NMDA receptor: Structure-activity relationships and possible therapeutic applications
14. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: Comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists
15. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: Pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy
16. Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs
17. AMPA receptors in epilepsy and as targets for antiepileptic drugs
18. Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: Quantitative in vitro receptor autoradiography
19. Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy
20. A new pyrrolylquinoxalinedione series of non-NMDA glutamate receptor antagonists: Pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy
21. Vigabatrin aggravates absences and absence status
22. Vigabatrin aggravates absences and absence status
23. Tiagabine-induced absence status in idiopathic generalized epilepsy
24. Studies of the lethargic (1h/1h) mouse model of absence seizures: Regulatory mechanisms and identification of the 1h gene
25. Aberrant expression of GABA(A) receptor subunits in the tottering mouse: An animal model for absence seizures
26. Pertussis toxin decreases absence seizures and GABA(B) receptor binding in thalamus of a genetically prone rat (GAERS)
27. Involvement of intrathalamic GABA(B) neurotransmission in the control of absence seizures in the rat
28. Neural network of structures in which GABA(B) receptors regulate absence seizures in the lethargic (1h/1h) mouse model
29. Synthesis of a new homologous series of p-chlorophenyl alcohol amides, their anticonvulsant activity and their testing as potential GABA(B) receptor antagonists
30. Opposite effects of GABA(B) receptor antagonists on absences and convulsive seizures
31. GABA and glutamate transporters: Therapeutic and etiologic implications for epilepsy
32. Hippocampal GABA transporter function in temporal-lobe epilepsy
33. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy
34. Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence
35. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents
36. Action of bicyclic isoxazole GABA analogues on GABA transporters and its relation to anticonvulsant activity
37. Carrier-mediated GABA release activates GABA receptors on hippocampal neurons
38. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro
39. Glutamate receptors and transporters in genetic and acquired models of epilepsy
40. EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and GABAergic neurons besides pyramidal cells in the rat cerebral cortex
41. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
42. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice
43. Expression of the glutamate transporters in human temporal lobe epilepsy
44. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
45. Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats
46. Alterations in glutamate transporter protein levels in kindling-induced epilepsy
47. Role of metabotropic glutamate receptors in epilepsy
48. Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability
49. Status epilepticus-induced alterations in metabotropic glutamate receptor expression in young and adult rats
50. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine
51. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala
52. Group I mGluR-mediated silent induction of long-lasting epileptiform discharges
53. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat
54. Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice
55. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo
56. Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid)
57. Pharmacological modification of amygdaloid-kindled seizures
58. Serotonergic inhibition of amygdalakindled seizures in cats
59. Eating disorder and epilepsy in mice lacking 5-HT(2c) serotonin receptors
60. Sound-induced seizures in serotonin 5-HT2c receptor mutant mice
61. Epilepsy and obesity in serotonin 5-HT(2C) receptor mutant mice
62. Serotonin (2C) receptors appear to mediate genetic sensitivity to cocaineinduced convulsions
63. Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats
64. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsyprone rats
65. Effects of serotonin on induced epileptiform activity in CA1 pyramidal neurons of genetically epilepsy prone rats
66. Neuronal networks in the genetically epilepsyprone rat
67. A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model
68. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: Dose response relationships
69. Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine(1A) receptor activation
70. Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats
71. Effect of fluoxetine on maximal electroshock seizures in mice: Acute vs chronic administration
72. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT(1A) receptors
73. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia
74. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography
75. Immunoreactivity of sera to a peptide derived from the serotonin 5-HT(1A) receptor in a group of children with developmental disorders: Possible role in non-autistic epilepsy
76. Neuroactive steroid modulation of [3H]muscimol binding to the GABA(A) receptor complex in rat cortex
77. A putative receptor for neurosteroids on the GABA(A) receptor complex: The pharmacological properties and therapeutic potential of epalons
78. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone
79. Neuroactive steroids: Potential therapeutic use in neurological and psychiatric disorders
80. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice
81. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alphahydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor
82. Progress report on new antiepileptic drugs: A summary of the fourth Eilat conference (EILAT IV)
83. Ganaxolone in the treatment of complex partial seizures: A double-blind, presurgical design
84. Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence
85. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20g 13.2
86. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy
87. Nicotinic receptor: A prototype of allosteric ligand-gated ion channels and its possible implications in epilepsy
88. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q
89. Evaluation of a putative major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q14
90. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy
91. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice